Thyrocare Technologies Limited has been honored with two prestigious awards at the 4th Edition of National Diagnostics Forum & Awards 2026. The recognition ceremony, organized by Voice of Healthcare (VOH), took place on January 21, 2026, at Courtyard by Marriott, Mumbai.

Awards Recognition

The company received recognition in two key categories that highlight its market leadership and service excellence:

Company's Mission and Values

The awards reflect Thyrocare Technologies Limited's core mission to ensure universal access to quality and affordable diagnostic services. The company has built its reputation on several key pillars that contributed to this recognition:

• Strong focus on patient-centric care
• Commitment to innovation in diagnostic services
• Operational excellence across its network
• Accessibility and affordability of diagnostic solutions

Regulatory Compliance

The company disclosed this achievement in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information has been made available on the company's investor website at investor.thyrocare.com/announcements/ for stakeholder access.

Event Details

The National Diagnostics Forum & Awards 2026 represents a significant industry platform that recognizes excellence in the healthcare diagnostics sector. The 4th edition of this event brought together industry leaders and stakeholders to celebrate achievements in diagnostic services and innovation.

This recognition underscores Thyrocare Technologies Limited's position as a leading diagnostic services provider in India, emphasizing its commitment to quality healthcare delivery and patient satisfaction.

Thyrocare technologies has scheduled an earnings conference call for January 28, 2026, at 5:30 PM IST to discuss its unaudited financial results for the quarter and nine months ended December 31, 2025. The announcement was made on January 20, 2026, pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Conference Call Details

The earnings call will provide analysts and investors an opportunity to interact with the company's senior management team regarding Q3FY26 performance. Multiple access options have been arranged to accommodate participants.

Management Participation

The conference call will be conducted by key members of Thyrocare Technologies' senior management team who will present the financial results and address questions from participants.

Regulatory Compliance

The earnings call announcement was formally communicated to both the National Stock Exchange of India Limited and BSE Limited. Company Secretary and Compliance Officer Brijesh Kumar signed the regulatory filing, ensuring compliance with listing obligations.

The conference call represents the company's commitment to maintaining transparent communication with its stakeholders regarding quarterly financial performance and business developments.